Suzanne M. Fields
- Oncology top 10%
- Cancer Treatment and Pharmacology 7
- Neutropenia and Cancer Infections 3
- Lung Cancer Research Studies 2
- Dermatology top 10%
- Chemotherapy-related skin toxicity 2
-
- Brain Metastases and Treatment 2
-
- Cancer therapeutics and mechanisms 3
-
- Multiple Myeloma Research and Treatments 2
-
- Nausea and vomiting management 1
- Co-authors
- Howard A. BurrisCeleste LindleyJohn R. EckardtJohn G. KuhnGladys RodriguezStephen A. BernardGeoffrey R. WeissDavid Rinaldi
- Journals
- Journal of Clinical Oncology (3 papers)Anti-Cancer Drugs (2 papers)Hematology/Oncology Clinics of North America (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
Suzanne M. Fields
15 papers receiving 582 citations
Peers
Comparison fields: 5 of 78
- Oncology 385
- Dermatology 44
- Pulmonary and Respiratory Medicine 143
- Cancer Research 49
- Genetics 34
Countries citing papers authored by Suzanne M. Fields
This map shows the geographic impact of Suzanne M. Fields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne M. Fields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne M. Fields more than expected).
Fields of papers citing papers by Suzanne M. Fields
This network shows the impact of papers produced by Suzanne M. Fields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne M. Fields. The network helps show where Suzanne M. Fields may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Suzanne M. Fields, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 2 | |
| 2 | 1996 | 34 | |
| 3 | 1995 | 132 | |
| 4 | 1994 | 29 | |
| 5 | 1994 | 2 | |
| 6 | 1994 | 28 | |
| 7 | 1994 | 55 | |
| 8 | Summary of data from in vitro and phase I vinorelbine (Navelbine) studies. | 1994 | 30 |
| 9 | 1994 | 40 | |
| 10 | 1993 | 120 | |
| 11 | A randomized phase I trial of chronic oral etoposide with or without granulocyte-macrophage colony-stimulating factor in patients with advanced malignancies. | 1993 | 14 |
| 12 | 1991 | 16 | |
| 13 | 1990 | 11 | |
| 14 | 1989 | 81 | |
| 15 | 1989 | 16 |
About Suzanne M. Fields
Suzanne M. Fields is a scholar working on Transplantation, Oncology, Hematology, Dermatology and Genetics, having authored 15 papers that have together received 610 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Cancer therapeutics and mechanisms (3 papers), Neutropenia and Cancer Infections (3 papers), Multiple Myeloma Research and Treatments (2 papers), Brain Metastases and Treatment (2 papers), Lung Cancer Research Studies (2 papers), Chemotherapy-related skin toxicity (2 papers) and Nausea and vomiting management (1 paper). The work is most often cited by research in Oncology (385 citations), Dermatology (44 citations), Pulmonary and Respiratory Medicine (143 citations), Cancer Research (49 citations) and Genetics (34 citations). Suzanne M. Fields has collaborated with scholars based in United States and France. Frequent co-authors include Howard A. Burris, Celeste Lindley, John R. Eckardt, John G. Kuhn, Gladys Rodriguez, Stephen A. Bernard, Geoffrey R. Weiss, David Rinaldi, Chris Langley and F. Andrew Dorr. Their work appears in journals such as Journal of Clinical Oncology, Anti-Cancer Drugs, Hematology/Oncology Clinics of North America, Investigational New Drugs and Cancer Nursing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.